tDCS + SLT for Post-Stroke Aphasia
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that combining transcranial direct current stimulation (tDCS) with speech language therapy (SLT) can help improve language skills in people who have trouble speaking after a stroke. Studies suggest that tDCS can enhance the effects of SLT, making it a promising approach for treating aphasia (language impairment) in stroke patients.
12345Research indicates that transcranial direct current stimulation (tDCS) combined with speech and language therapy (SLT) is generally safe for humans, with no serious adverse events reported in studies involving stroke survivors with aphasia.
35678The tDCS + SLT treatment is unique because it combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate the brain, with speech and language therapy (SLT) to enhance language recovery in stroke survivors with aphasia. Unlike standard treatments, this approach targets the brain's language areas directly and has shown potential for greater language improvement when used over an extended period.
12369Eligibility Criteria
This trial is for individuals aged 18-80 who have had a stroke on the left side of their brain at least 6 months ago, resulting in aphasia. They must speak English natively and have good hearing and vision. People with severe comprehension deficits, other neurological diseases or major mental illnesses, conditions not suitable for MRI or tDCS (like seizures), or pregnant women cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Baseline Assessment
Participants complete the Neuropsychological Testing Battery and the first round of outcome measures as pre-testing before starting SLT
Intervention Phase 1
Participants receive 2 weeks of Speech-Language Therapy (SLT) with either active tDCS or sham tDCS
Outcome Testing 1
Participants complete post-testing for the 1st SLT phase and pre-testing for the 2nd SLT phase
Intervention Phase 2
Participants receive another 2 weeks of SLT with the other tDCS condition
Outcome Testing 2
Participants complete post-testing for the 2nd SLT phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Active Transcranial Direct Current Stimulation with SLT is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation